The Valley Desk

Clinical trial reportThe international journal of neuropsychopharmacologyPublished

Weight and metabolic changes in patients with schizophrenia treated with paliperidone palmitate 6-month formulation versus paliperidone palmitate 3-month formulation: a post-hoc analysis

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Clinical trial report
Venue
The international journal of neuropsychopharmacology
Published
Subject terms
Humans; Body Weight; Lipids; Antipsychotic Agents; Delayed-Action Preparations; Body Mass Index; Double-Blind Method; Schizophrenia; Adolescent; Adult; Middle Aged; Female
PubMed ID
42623271
PubMed Central ID
PMC13533545
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal